Mk I Personal Interim Pharmacologic Treatment Module [PIPTM]
The prevalence of remote, inaccessible theaters of operations of special forces has long been a medical triage dilemma. However, many deaths of operatives could be avoided if adequate stopgap treatment was administered in the field. Research and engineering advancements in miniaturization and replication technology have now made it possible to make personal scanning instruments and pharmacologic production small enough that a small, light device can be placed on a person that can withstand the rigors of battlefield operations. The PIPTM is capable of introducing drugs appropriate to thousands of diseases, disorders, and wounds recognized by Starfleet Medical in most any amount contained within the medical database comparator/analysis subsection (MDC/AS). It can also be used as a preliminary medical status assessing tool. Any paramedic can download the data with the touch of a single button to a standard tricorder for near instantaneous assessment of the patient's condition. Each PIPTM is specialized with the physiologic history of the bearer in order to minimize possible allergic reactions and reduce treatment time by not administering agents known to be ineffective to that individual.
Size: 15 cm x 5 cm x 3 cm Weight: 100 grams Powerplant: Sarium crystal rated at 50 hour use Power consumption: 5 watts
Interface: Reduced LCARS positive feedback terminal
Sensors: mechanical/kinetic impression sensor, electromagnetic node complex
Data Storage: Bio-Neural Gel Pack
Administration Kinetics: Intravenous/Intramuscular/Subcutaneous hypospray, Transdermal Osmotic Contact Pad
Treatment source: 50 g inert organic base
Proposed by Capt David Sands, CO USS Apocalypse, Chief Special Operations Weapons Tester/Researcher.